Related by context. All words. (Click for frequent words.) 78 Significant Milestones 75 Patient Enrollment 74 Lupus Drug 74 Nasdaq Delisting Notice 74 Significant Milestone 74 Strengthens Balance Sheet 74 Lung Cancer Drug 74 Migraine Drug 73 Phase 1b Clinical Trial 73 Milestone Payment 73 Issues Shareholder 73 Receives Milestone Payment 73 Milestone Achieved 73 First Patient Treated 72 Nanophase Announces 72 Completes Patient Enrollment 72 Tremendous Growth 72 NDA Submission 72 Epilepsy Drug 72 Lifts FY# Outlook 72 IND Filing 72 Gout Drug 72 Backs FY# View 72 First Patient Enrolled 72 Cash Flow Positive 72 Merge Healthcare Announces 72 Therapeutic Antibody 72 Clinical Trial Enrollment 72 Balance Sheet Restructuring 71 XPEL Announces 71 Flamel Technologies Announces 71 Nasdaq Deficiency Notice 71 Immunomedics Announces 71 Employment Inducement Awards 71 Submits NDA 71 Backs FY# Forecast 71 Revises FY# Guidance 71 ANADIGICS Announces 71 Pending Acquisition 71 Restructures Debt 71 Nasdaq Notice Regarding 71 Industry Accolades 71 Important Milestone 71 Rheumatoid Arthritis Drug 71 Reaffirms FY# Guidance 71 Receives Orphan Drug 71 Upcoming Webinar 71 Backs FY# Outlook 71 Diamyd Medical Diamyd 71 Taro Receives 71 Lifts FY# Guidance 71 Guides FY# Earnings 71 Crowflight Announces 71 Achieves Milestone 71 Revises FY# Outlook 71 TriCo Bancshares Announces 71 FDA Approvals 70 Ebola Vaccine 70 Shrs Rise 70 Accelerate Commercialization 70 Phase 2b Trial 70 Achieves Significant 70 Enhanced Version 70 Poniard Pharmaceuticals Announces 70 Achieves Record Sales 70 Patent Infringement Litigation 70 XTend Medical XMDC 70 Positive Cash Flow 70 NuMobile NUBL 70 Patents Issued 70 Sixth Consecutive Quarter 70 Clinical Trial Data 70 Private Equity Financing 70 Momentum Continues 70 Board Authorizes 70 Unsolicited Proposal From 70 Expand Collaboration 70 Major Step Toward 70 Files IND 70 Univest Corporation Declares 70 Buyback Plan 70 Provides Shareholder 70 Begins Shipment 70 Demonstrates Significant 70 Million Convertible Debt 70 PPD Declares 70 Ducommun Incorporated Announces 70 GeoMet Announces 70 Projected Release Date 70 Systemic Delivery 70 Announce Collaboration Agreement 70 Reaffirms FY# Outlook 70 Lowers FY# Outlook 70 Continues Momentum 70 Liver Toxicity 70 Nuvelo Announces 70 Pharmacyclics Announces 69 Resubmission 69 Drug Candidate 69 FY# Guidance 69 RNAi Therapeutics 69 Integra LifeSciences Announces 69 StockSource.us Reports USOG 69 Arthritis Drug 69 FY# EPS View 69 Backs FY# Guidance 69 Organizational Changes 69 AVI BioPharma Announces 69 Prostate Cancer Vaccine 69 NASDAQ Listing Requirements 69 Strengthens Leadership 69 Present Preclinical Data 69 Files Patent Application 69 Extends Collaboration 69 Reaffirms Outlook 69 Wizzard Software Announces 69 Quarterly Dividend Payment 69 Upcoming Conferences 69 Spectrum Pharmaceuticals Announces 69 Successfully Completes Phase 69 Provides Status 69 Miraculins Announces 69 Amends Agreement 69 Medicure Announces 69 Significantly Expand 69 Improves Survival 69 Obtains Financing 69 DOR BioPharma Announces 69 Winmark Corporation Announces 69 Rapid Expansion 69 EntreMed Presents 69 Accelerates Growth 69 Cholesterol Drug 69 Contract Signings 69 Meets Primary Endpoint 69 Receive Milestone Payment 69 Phase IIb Clinical Trial 69 Granted Orphan Drug 69 Zix Corporation Announces 69 Nicotine Vaccine 69 Threshold Pharmaceuticals Announces 69 Announce License Agreement 69 Shows Promising 69 Novel Protein 69 Backs FY# Revenue 69 Phase 2a Trial 69 Strengthen Balance Sheet 69 Receives Approvable Letter 69 Updates Guidance 69 Japanese Stocks Climb 69 PDL BioPharma Announces 69 Pacific Rubiales Announces 69 Neutral Analyst Blog 69 Previously Announced Private Placement 69 Clinical Trial Results 69 Million Milestone Payment 68 Pre Cancerous 68 Completes Enrollment 68 Successful Completion 68 Commences Phase 68 Annual Meeting Date 68 Earns Milestone Payment 68 Purported Class 68 Expands Portfolio 68 Anticancer Activity 68 NUBL NuMobile 68 Guides FY# FY# 68 Receives Funding 68 Stock Buyback Plan 68 Broadens Scope 68 Nasdaq Delisting 68 Re Affirms 68 Initiates Clinical Trial 68 Proves Successful 68 Multiple Fronts 68 Reduces Debt 68 Mln Share Buyback 68 Survival Benefit 68 Confirmatory Phase 68 Margin Expansion 68 Unveils Groundbreaking 68 Measurement Specialties Announces 68 Receives Orphan Drug Designation 68 Momentum Grows 68 CFO Resignation 68 Receives Fast Track 68 MOTOROLA Motorola 68 Significantly Improved 68 Achieves Positive 68 Enters Definitive Agreement 68 Significantly Increases 68 Enters Into Definitive 68 Medoro Resources Announces 68 ISSI Announces 68 HCV Protease Inhibitor 68 Successfully Completed 68 Study Shows Benefits 68 Reiterates Fiscal 68 Patent Infringement Suit 68 Kaydon Corporation Announces 68 Gene Variants 68 Widespread Adoption 68 Sangamo BioSciences Announces 68 Fourth Quarter Cash Dividend 68 WTC Rebuilding 68 FY# EPS Forecast 68 Preclinical Data 68 Secures Financing 68 Productivity Gains 68 Signs Definitive Agreements 68 Inks MOU 68 Flagship Product 68 Announces Definitive Agreements 68 Initiate Phase III 68 Audited Financials 68 BIOLASE Announces 68 Achieves Record Revenue 68 Inhaled Insulin 68 Double Digit Earnings 68 Dose Ranging 68 Outlines Strategy 68 Q2 Loss Widens 68 CorVel Announces 68 Milestone Payment From 68 Phase 2b Clinical Trial 68 Develop Next Generation 68 KB Home Swings 68 Q3 Loss Narrows 68 Q3 Profit Decreases 68 Reaffirms FY# EPS 68 Nasdaq Delisting Notification 68 Widest Range 68 Third Consecutive Quarter 68 Genetic Defect 68 Q4 Profit Decreases 68 Continues Steady 68 Settle Patent Litigation 68 Broadens Its 68 Q2 Adj 68 Financing Commitment 68 Gene Variation 68 Announce Interoperability 68 Aethlon Medical Releases 68 Reverses Loss 68 Evaluate Strategic Alternatives 68 Closes Oversubscribed 68 Provide Seamless 68 Develop Novel 68 Provides Update Regarding 68 Demonstrates Commitment 68 Share Buybacks 68 Novel Antibiotic 68 Amend Merger Agreement 67 Schizophrenia Drug 67 Underwritten Public 67 First Patient Dosed 67 FDA Clears 67 Psoriasis Drug 67 Financing Transactions 67 Schweitzer Mauduit Announces 67 Opns 67 Reduces Size 67 Milestone Reached 67 Collaborators Present 67 Palladon Announces 67 Issues Clarification 67 Initiates Clinical 67 Drug Fails 67 VIVUS Announces 67 Biologic Drugs 67 Topline Results 67 WebTech Wireless Announces 67 NMT Medical Announces 67 Identifies Potential 67 Randomized Trials 67 Debt Offerings 67 Hepatitis C Treatment 67 FDA Accepts 67 Signs Option Agreement 67 TB Vaccine 67 Vaccine Adjuvant 67 Reduce Expenses 67 Share Repurchases 67 Announces FDA Clearance 67 Corcept Therapeutics Announces 67 Ticker Symbol Change 67 Licenses Patents 67 Secures Additional 67 OTC MNDP 67 Product Enhancements 67 Awarded Patents 67 FY# Loss Widens 67 Volume Shipments 67 Oceaneering Announces 67 Antibody Drug Conjugate 67 Voice Enabled 67 Customer Deployments 67 Receives NASDAQ 67 Initiates Phase II 67 Global Reseller Agreement 67 Ramco Gershenson Announces 67 Sono Tek Announces 67 Lifts FY# Revenue 67 Randomized Clinical Trials 67 CFO Resigns 67 Stock Repurchase Authorization 67 PremierWest Bancorp Announces 67 Pandemic Influenza Vaccines 67 NASDAQ Delisting 67 Newly Identified 67 Streamlines Operations 67 Industry Luminaries 67 Achieves Record Revenues 67 Avian Flu Vaccine 67 Demonstrates Ability 67 SulphCo Announces 67 OTCBB DTRO 67 Reaffirms Guidance 67 Gene Mutations 67 BRE Properties Announces 67 Q4 Profit Plunges 67 Million Share Buyback 67 Non Dilutive Financing 67 Improves Accuracy 67 Asset Swap 67 Reconfirms 67 Results Exceed Expectations 67 Male Contraceptive 67 WallSt.net Announces 67 JAK2 Inhibitor 67 Completes Reorganization 67 Phase 2a Clinical Trial 67 PDUFA Date 67 Updates FY# EPS 67 Reaffirms FY# Revenue 67 Blood Pressure Drug 67 Announces Profitable 67 Initiates Enrollment 67 Patented Technology 67 Deliver Powerful 67 Cancer Stem Cells 67 Patent Filing 67 Takeover Speculation 67 Testosterone Gel 67 HemaCare Reports 67 Signs Merger Agreement 67 KEMET Announces 67 Novel Antibody 67 Announces Rebranding 67 Neoadjuvant Chemotherapy 67 Dramatically Expands 67 Vigorously Defend 67 Asthma Treatment 67 Consolidates Operations 67 Boosts Productivity 67 IDEXX Laboratories Announces 67 Continues Aggressive 67 Upcoming Investor 67 Derma Sciences Announces 67 TriMas Corporation Announces 67 Solution Achieves 67 Accelrys Announces 67 Billion Stock Repurchase 67 Shareholder Meeting Date 67 Q2 Loss Narrows 67 Confirms Commitment 67 Host Teleconference 67 Submits Application 67 Licensing Pact 67 Bladex Announces 67 Oncology Compounds 67 Explore Strategic Alternatives 67 Results Confirm 67 Closes Financing 67 Announces Share Buyback 67 License Pact 67 Cholesterol Lowering Drug 67 Milestone Payments 67 Profitable Second Quarter 67 Definitive Merger Agreement 67 Lifts FY# Earnings 67 Recent Accomplishments 67 Monetizes 67 Trims Loss 67 Increasing Importance 67 Stock Buyback Program 67 Provides Guidance 67 Previously Disclosed 67 Share Issuance 67 Possible Takeover 67 Genetic Mutations 67 Pooled Analysis 67 CECO Environmental Announces 67 Shingles Vaccine 67 Anounces 67 Drug Combo 67 Transaction Valued 67 BioElectronics Corporation Announces 67 Insteel Industries Announces 67 Double Digit Revenue 67 Restructures Operations 67 Study Evaluates 67 Patent Lawsuit Against 67 Renewed Commitment 67 Expands Scope 67 Anti Clotting Drug 66 Provides Clarification 66 Consecutive Quarters 66 BioElectronics Announces 66 Plans Job Cuts 66 Guidance Quick Facts 66 Develop Innovative 66 Lifts FY# 66 Accelerate Growth 66 Reiterates FY# 66 Prolongs Survival 66 Malaria Vaccine 66 Identifies Key 66 Pricing Structure 66 Completes Transaction 66 Exceeds Guidance 66 Presents Preclinical Data 66 Wider Loss 66 LiLo Looks 66 Mln Private Placement 66 Osteoporosis Drug 66 Reaffirms Fiscal 66 ViRexx Announces 66 Gain Traction 66 Achieves Profitability 66 Dose Escalation 66 Billion Share Buyback 66 Biotech Firm 66 Vertex Pharmaceuticals Announces 66 STERIS Corporation Announces 66 Hugely Successful 66 FelCor Announces 66 Orckit Communications Reports 66 WGNB Corp. Announces 66 Fundamental Shift 66 Regains NASDAQ 66 Cleaner Coal 66 Increases Guidance 66 Proxy Proposals 66 Accelerate Adoption 66 Successful Implementation 66 Growth Trajectory 66 For Undisclosed Terms 66 Certified Partner Status 66 Uncertainty Remains 66 Successful Conclusion 66 Genes Involved 66 Completes Transition 66 Legal Dispute 66 Completes Restructuring 66 Emphasizes Importance 66 Has Commenced 66 Significant Improvements 66 Patent Infringement Suit Against 66 Reaches Profitability 66 FNDS# Corp Announces 66 Helps Predict 66 Quick Facts2 66 Revises Full 66 Upcoming Milestones 66 Jumps Higher 66 Flexsteel Announces 66 Initiates Clinical Trials 66 Statin Drugs 66 Announces Discontinuation 66 Virco Announces 66 Cervical Cancer Vaccine 66 Has Been Awarded 66 Phase III Trials 66 Clinical Outcome 66 Common Share Repurchase Program 66 FDA Okays 66 Unsolicited Proposal 66 Stereotaxis Announces 66 Evergreen Closed End 66 Oral Presentations 66 Investigational Agent 66 Blast Applications BLAP 66 Q1 Loss Widens 66 Settle Shareholder 66 Testosterone Patch 66 IBERIABANK Corporation Reports 66 Initiates Phase III 66 StockSource.us Reports 66 Bingo.com Announces 66 Fifth Consecutive 66 Delayed Filing 66 Revises FY# EPS 66 NASDAQ Deficiency Notice 66 Previously Announced 66 Product Differentiation 66 Anticancer Drug 66 Genetic Mutation 66 Privacy Breaches 66 Above Consensus 66 Live Attenuated 66 Strengthens Position 66 Builds Momentum 66 Q1 Loss Narrows 66 Boosts Buyback 66 Antitumor Activity 66 NOVAVAX 66 Phase III Clinical Trial 66 Underscores Commitment 66 Geokinetics Announces 66 Antiviral Drugs 66 Next Step Toward 66 Losses Narrow 66 Cost Reductions 66 Single Dose 66 Unveils Expanded 66 Debt Refinancing 66 Enhance Shareholder Value 66 Fourth Consecutive Quarter 66 Reiterates FY# Outlook 66 Quadruples 66 Ups Guidance 66 Receives Approvals 66 Successful Deployment 66 Cash Infusion 66 Proven Effective 66 Provides Detailed 66 Sixth Consecutive Year 66 Initiates Dosing 66 Patent Lawsuit 66 Greatly Improves 66 Subsidiary Enters 66 Achieves Unprecedented 66 Newmont Declares Regular 66 ΞΕΝΗ ΔΗΜΟΣΙΕΥΣΗ ΑΝΑΚΟΙΝΩΣΗInfosys Finacle 66 Unsolicited Tender Offer 66 Exercises Option 66 Lifts Dividend 66 Inflation Fears Ease 66 Habersham Bancorp Announces 66 Terminate Merger Agreement 66 Protherics PLC announces 66 Face Transplants 66 Prostate Cancer Patients 66 Atwood Oceanics Announces 66 Completes Previously Announced 66 Gluten Powder 66 Expand Scope 66 Significant Reduction 66 Generates Record 66 Reseller Relationship 66 Substantially Improved 66 Receives CE Marking 66 Report Analyzes 66 Vantex Completes 66 Site Redesign 66 Provides FY# EPS 66 Shareholder Letter 66 Jointly Announce 66 Drug Coated Stent 66 Profitable Third Quarter 66 Multicore Processor 66 Demand Soars 66 Cell Phone Shipments 66 Issued Patent 66 Shares Soar 66 Altera Ships 66 Information Portal StockProfile.com 66 #.#B Buyout [003] 66 Genes Predict 66 Automation Capabilities 66 Affirms FY# 66 Introduces Breakthrough 66 Updates Shareholders 66 Backs FY# 66 Oroco Announces 66 Genetic Variations 66 Fold Increase 66 Q3 Loss Widens 66 Reduces Cost 66 Metabolic Disorder 66 Renal Cancer 66 Merger Discussions 66 JAK Inhibitor 66 Flexpoint Announces 66 Buyout Proposal 66 Phase III Trial 66 Q1 Profit Plunges 66 Settle Litigation 66 Q1 Profit Decreases 66 Advanced Melanoma 66 Narrows 4Q Loss 66 EUR# Mln 66 Stock Buyback 66 Contaminated Heparin 66 Ownership Structure 66 Enters Into Definitive Agreement 66 Stock Plunges 66 Going Concern Qualification 66 Protein Synthesis 66 Novel Vaccine 66 #nm Process 66 Troop Withdrawl 66 Anti Inflammatory Drug 66 Review Strategic Alternatives 66 Quarter Earnings Release 66 Hiru Corporation HIRU 65 Diagnostic Tools 65 Excellon Announces 65 Reaffirms Earnings 65 LightPath Technologies Announces 65 Regulatory Clearance 65 Stem Cell Treatment 65 Refocuses 65 Drug Shows Promise 65 NYSE Amex Listing 65 Predict Risk 65 Halmont Properties Corporation 65 Attract Buyers 65 Breast Cancer Stem Cells 65 Eighth Consecutive 65 Biopharmaceutical Industry 65 Significant Increase 65 Advisers Urge 65 InternetArray Noobis 65 Anworth Announces 65 Achieves Milestones 65 Marks Milestone 65 SmallcapInsights.com Article 65 Whole Genome Sequencing 65 Encision Reports 65 Higher Margins 65 Record Second Quarter 65 Gain Competitive Edge 65 Airwaves Auction 65 Session Highs 65 Rotavirus Vaccine 65 Fully Functional 65 OxyContin Maker 65 Shows Promise Against 65 Influenza Vaccine Production 65 Sagging Economy 65 Confirms Guidance 65 Reaffirms FY# Earnings 65 Anticancer Agent 65 Shares Plummet 65 Phase IIb Trial 65 Diversifies 65 Bombardier CSeries Aircraft 65 ESCO Announces 65 Primary Efficacy Endpoint 65 Reaffirms Full 65 #.#M cbl [003] 65 Oil Tumbles 65 Loss Shrinks 65 Enables Rapid 65 Demonstrates Sustained 65 Prostate Tumors 65 Receives Unsolicited 65 Helps Organizations 65 Forecast Quick Facts 65 Anti CD# Antibody 65 Surpasses Expectations 65 Optimistic Outlook 65 Celebrates Successful 65 Patents Covering 65 Sixth Consecutive 65 Secures Funding 65 Genes Linked 65 Q1 Profit Dips 65 Artery Disease 65 First Fully Integrated 65 Azure Dynamics Announces 65 Revises FY# 65 Announces Initiation 65 Results Reflect 65 Completes Financing 65 Successfully Concludes 65 Weight Loss Drug 65 Backs FY# Earnings 65 Lifts FY# EPS 65 Upcoming Investor Events 65 Recession Worries 65 Polysilicon Production 65 Expands Globally 65 Completes Tender Offer 65 Dollar Sags 65 Multi Billion Dollar 65 Rat Poison Found 65 Xenonics Announces 65 Acquire Controlling Interest 65 Sharpens Focus 65 Hikes Dividend 65 4Q Profit Slides 65 Contracts Totaling 65 Senetek PLC Announces 65 Critical Patches 65 Multiple Myeloma Patients 65 Double Digit Growth 65 Q3 Adj 65 Announces Cancellation 65 Unveils Breakthrough 65 Strengthened Balance Sheet 65 Voluntary Withdrawal 65 Antibiotic Treatment 65 Cites Positive 65 Patients Suffering 65 Midday Trading 65 Final Stages 65 Intellectual Property Portfolio 65 Stock Soars 65 Webcast Presentations 65 Anti Nausea 65 Analyst Downgrade 65 Dividend Hike 65 First BanCorp Announces 65 Posts Profitable 65 Approves Share Repurchase 65 Issues Resolved 65 GRAS Status 65 Lowers FY# EPS 65 Q4 Adj 65 Buy Privately Held 65 Guidance Reaffirmed 65 Synalloy Corporation Announces 65 DTC Eligibility 65 Delivers Unprecedented 65 Beats Forecast 65 Licensing Agreements 65 Chemotherapy Regimen 65 Option Grants 65 Expands Capabilities 65 Q1 FY# EPS 65 Announces Licensing Agreement 65 Boosts FY# 65 Announce Merger Agreement 65 Enables Seamless 65 Anemia Drug 65 Faces Setback 65 Enables Faster 65 Provides Updates 65 Invoke Fifth Amendment 65 Growth Oriented 65 Revises Guidance 65 Stem Cell Procedure 65 Bit Computing 65 Technological Advances 65 SABESP Announces 65 Percent Jump 65 Oral Laquinimod 65 Most Widely Used 65 Closes Merger 65 Record Third Quarter 65 Enhanced Capabilities 65 Inter Citic Releases 65 Efficiently Manage 65 Highly Prospective 65 See AlcaLu 65 Total Knee Arthroplasty 65 Obtains Exclusive License 65 Announcement acc 65 Major Averages Continue 65 Mln Stock Buyback 65 Aethlon Medical Announces 65 Million IDIQ Contract 65 Restate Financials 65 Transplant Patients 65 Warrants Exercised 65 Liver Transplant Patients 65 Artificial Pancreas 65 Cut Carbon Emissions 65 Raser Technologies Announces 65 Terminate Merger 65 Mad Cow Testing 65 Unsolicited Bid 65 Files Investigational 65 Sees Continued Growth 65 COMPETITIVE LANDSCAPE Total 65 Buyout Talks 65 Authorizes Share Repurchase 65 Gets FDA Clearance 65 Aggressive Prostate Cancer 65 Adverse Outcomes 65 Novel Therapies 65 FOREX Ringgit Likely 65 Achieves CMMI Level 65 Presents Positive 65 Achieve Breakthrough 65 Vaccine Adjuvants 65 Supply Chain Efficiencies 65 Barbaro Suffers 65 Exponential Growth 65 Aggressive Expansion 65 Painkiller Abuse 65 Secures Patent 65 Oral Calcitonin 65 Steady Decline 65 Guides Q4 65 Larger Than Expected 65 Addresses Critical 65 Less Invasive 65 Announces Publication 65 Molecular Diagnostic 65 Gene Variant 65 Colorectal Cancer Patients 65 Lung Cancer Survival 65 Files Shelf Registration Statement 65 Provides Unprecedented 65 Announces Ticker Symbol 65 Explores Strategic Alternatives 65 Photovoltaic Module 65 Patients Enrolled 65 Patent Infringement Lawsuit 65 Cholesterol Drugs 65 Flu Strains 65 Explosive Growth 65 Respiratory Distress 65 Collaborators Publish 65 Teva Provides Update 65 Treating Depression 65 Symbol GRYE 65 Boosts Guidance 65 Deliver Comprehensive 65 China Crescent CCTR 65 Imaging Technique 65 Measurement Capabilities 65 Share Buyback Program 65 Combination Treatment 65 Anti Tumor 65 Cautious Outlook 65 Commercializes 65 Acne Drug 65 Licenses Novel 65 Backs FY# EPS 65 Redesigned Website 65 Buyout Speculation 65 Receives Permission 65 Wall Street Fluctuates 65 Phase Ib Clinical Trial 65 Technological Advancements 65 Diagnostic Tests 65 Terminate Agreement 65 Stocks Wobble 65 Generic Protonix 65 Newly Introduced 65 Healthnostics Announces 65 Drug Resistant Tuberculosis 65 Macusani Yellowcake Announces 65 Irvine Sensors Releases 65 Volatile Session 65 Contract Renewals 65 Lowers Forecast 65 Reveals Significant 65 Phenomenal Growth 65 Guidelines Issued 65 Collaboration Capabilities 65 Clot Risk 65 Clinical Study Shows 65 MBMI Closes 65 Expand Relationship 65 Cell Transplants 65 FFO Per Share 65 Announces Favorable 65 QHR Announces 65 Losses Widen 65 Outlines Steps 65 RNAi Therapeutic 65 Stock Tumbles 65 TiVo Posts Narrower 65 Booster Shot 65 Anti Tumor Activity 65 Posts Wider Loss 65 Delivers Next Generation 65 Spending Slows 65 Q1 Adj 65 Positions Itself 65 Patent Infringements 65 SEACOR Holdings Announces 65 Symmetricom Announces 65 Achieves Record Growth 65 Nasdaq Listing Requirements 65 Virtualization Offerings 65 Makes Headway 65 Strategic Acquisitions 65 Due Diligence Process 65 Sagent Pharmaceuticals Announces 65 Highlights Include 65 Irvine Sensors Receives 65 Extends Capabilities 65 Evaluating Strategic Alternatives 65 Shareholder Suits 65 Lowers Guidance 65 Q2 Profit Plunges 65 Smartphone Shipments 65 CompanionLink Announces 65 Announces Spin Off 65 Growing Importance 64 Stem Cell Breakthrough 64 Generic Biologics 64 EHR Adoption 64 Enters Option Agreement 64 Jennifer Convertibles Reports 64 Taglich Brothers Initiates Coverage 64 Narrower Loss 64 Combination Clinical Trial 64 Announce Commencement 64 Announces Debt Settlement 64 Statistically Significant 64 Diageo DEO PriceWatch Alert 64 Protein Biomarker 64 Receives Shareholder Approval 64 Renewable Energy Projects 64 Narrows FY# EPS 64 Executes Definitive 64 Shareholder Lawsuit 64 Critical Fixes 64 Lags Estimates 64 Upcoming Investor Conferences 64 Jointly Offer 64 Obese Teens 64 Restate Results 64 Generic Version 64 Lung Cancer Trial 64 Biomarker Study 64 Strengthens Relationship 64 Oil Prices Plummet 64 Announces Organizational Changes 64 Patent Suits 64 Margin Improvement 64 Converged Networking 64 Lowered Guidance 64 Pivotal Trials 64 Bought Deal Financing 64 Internationally Recognized 64 Net Loss Narrows 64 Settle Patent 64 Strategic Alternatives Review 64 Tentative Approval 64 NexgenRx Announces 64 Bulk Sampling Program 64 Concludes Acquisition 64 Breast Cancer Cells 64 Seasonal Influenza Vaccine 64 Strengthens Commitment 64 Novel Oral 64 QIAGEN QGEN 64 Shuttle Launch Date 64 Files Voluntary 64 Despite Economic Downturn 64 ViaSat Receives 64 FDA Panel Recommends 64 Contracts Awarded 64 Trims Outlook 64 Epilepsy Drugs 64 Flu Vaccine Shortage 64 Social Networking Features 64 #M Buyback [001] 64 Heska Announces 64 Antigen Specific 64 Sign License Agreement 64 TowneBank Announces 64 Pending Merger 64 Combo Therapy 64 Device Maker 64 Q1 Profit Surges 64 Fortifies 64 Acute Heart Failure 64 TriMas Corporation Reports 64 Intertainment Itibiti Systems 64 Analyst Upgrade 64 Chart Presentation 64 Becomes Easier 64 Extends Tender Offer 64 Advocat Announces 64 Plans Buyback 64 Hythiam Announces 64 Workforce Reduction 64 Q2 Profit Decreases 64 Complete Merger 64 Guides Q3 64 Passes Milestone 64 CNinsure Announces 64 Smallpox Vaccine 64 Successfully Completes Tender Offer 64 Board Unanimously Rejects 64 Robust Growth 64 Study Casts Doubt 64 Upcoming Deadline 64 ScottsMiracle Gro Announces 64 Continues Climb 64 Completes Reverse Merger 64 Expand Capabilities 64 Substantial Increase 64 Debt Tender Offers 64 Revamps Website 64 MEDTOX Scientific Announces 64 Exceed Forecast 64 reaffirms FY# outlook 64 Planned Acquisition